Aeglea BioTherapeutics Withdraws Public Offering
AUSTIN, Texas, Feb. 10, 2022 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (Nasdaq:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeu…
More from Central Texas
Killeen Daily Herald
Bell County candidates debate taxes, education and growth at LULAC forum
Central Texas
•
1m ago
Hill Country News | Cedar Park
Taxpayers pay the price when Texas education department takes over school districts
Central Texas
•
45m ago
Killeen Daily Herald
Does the planned execution of Nidal Hasan carry potential risks?
Central Texas
•
1h ago
Killeen Daily Herald
More than a blemish: Temple dermatologist explains basal cell carcinoma and why early detection matters
Central Texas
•
1h ago
Killeen Daily Herald
House District 55 candidates offer contrasting visions on education, veteran tax relief
Central Texas
•
2h ago
